Smiths Group plc’s Post

Often it can be challenging to understand the #financial #jargon in #earnings #reports. After a conversation with several team members, I realized the importance of explaining these concepts more clearly. Therefore, I want to dedicate this post to #explaining Hologic, Inc. . results for this quarter in a straightforward way, using key numbers and financial terms but also explaining what they mean. Simple Summary of the #Quarter's #Results: Hologic, Inc. . had a #good #quarter, and here are the key points: - #Total #Revenue: Hologic, Inc. . earned a total of $1,011.4 million. This includes all the money the company received from selling #products and #services. This amount is 2.7% higher than what we earned in the same period last year, meaning our #sales have #increased. - #Earnings per Share (#EPS): EPS stands for "earnings per share" and is a way to show how much money the company made for each piece of the company, called a #share. This quarter, Hologic, Inc. made $0.82 for each share. This number is based on #GAAP (Generally Accepted Accounting Principles), which are the rules companies follow when they report their finances. However, sometimes there are special, one-time costs or events that aren't part of the regular business. If we take those out, we get a #Non-GAAP EPS of $1.06. This gives a clearer picture of how the company is doing day-to-day without the unusual events. - #Revenue #Growth: Total revenue increased by 2.7%, indicating #growth in our sales. If we exclude revenue related to COVID-19 products, the growth was 5.8%. This is important because it shows we are #selling more of our other products, not just those related to the pandemic. Performance in Different Areas: - #Diagnostics: In this area, which focuses on tests to detect diseases, we saw a slight increase of 0.3% in revenue. However, within this, molecular diagnostics (which are more specific tests) grew by 2.8%. - #Breast Health: Here, our sales increased by 6.9%, driven by higher demand for imaging equipment for diagnosing breast diseases. - #Surgical Gynecology:This area grew by 5.9%, with products like MyoSure, used in surgeries to treat uterine issues, being particularly popular. Other aspects: - #Share Buyback: Hologic repurchased 1.4 million of its own shares for $100 million. Buying back shares can be a sign that the company is #confident in its #future. - #Acquisition of Endomag:This new #acquisition specializes in technologies for breast surgeries, #expanding our range of products and services. In summary, Hologic, Inc. . had a solid quarter and continues to grow in several key areas. These results show that we are well-positioned to keep improving and #helping #more #people with our health #products. #Congratulations to everyone who is a part of this company and contributes their effort to achieving these strong results. It's a true team effort that keeps us moving forward!

Today, we shared our Q3 trading update for the fiscal year 2024.   We posted +7.7% organic revenue growth for the quarter, with all four of our businesses, John Crane, Smiths Detection, Flex-Tek and Smiths Interconnect contributing to this performance. This builds on the record growth we achieved in the same period last year and gives us year-to-date organic revenue growth of +5.2%. Q3 this year benefited from four extra trading days and adjusting for this, the Q3 organic growth on a comparable basis was +6.1% (YTD 4.6%.)   We are also reaffirming our FY2024 guidance today of full-year organic revenue growth of 4-6%, with continued margin expansion.   Read more on our trading update here: https://lnkd.in/eBK8G9Gh   #ProudToBeSmiths

Wall Street Week Ahead PLTR, YUM, ARM, QCOM, VRTX, CEG, ZTS, MAR, AIG, FANG, ILMN, RACE, APO, EMR, MPC, CMI, MCHP, DD, QSR, ADM, TM, GILD, MELI, CVS, MCK, WMB, SRE, JCI, CTVA, TTWO, ANET, DUK, ABNB, PBR, MSI, APD, BDX, FTNT, SQ, TU, NRG, BAX, PARA, PARAA, CNH, FLR, ERJ To say next week is pivotal is probably understating it. Wall Street awaits with bated breath the outcome of the U.S. presidential election on Tuesday, in a season that has seen plenty of twists and turns. Various polls have placed U.S. Vice President Kamala Harris and Republican opponent Former President Donald Trump neck-and-neck for the White House, while prediction platforms have swung between the two candidates. The election will be followed by the penultimate Federal Reserve monetary policy committee meeting of the year, commencing on Wednesday. On Thursday, policymakers will announce their decision. Since the central bank's bumper half-point rate cut in September, incoming data has suggested a continued deterioration in the labor market, an economy that was still chugging along, and an inflation situation that may not be completely out of the woods yet. It keeps the Fed on track to deliver another interest rate cut next week, and markets expect it to be a 25 basis point decrease. The earnings season will continue to chug along. High-profile companies on tap to announce their results include Palantir Technologies (PLTR), Yum! Brands (YUM), Arm (ARM) and Qualcomm (QCOM). Earning Spotlight: Monday, November 4 - Vertex Pharmaceuticals (VRTX), Palantir Technologies (PLTR), Constellation Energy (CEG), Zoetis (ZTS), Marriott International (MAR), American International Group (AIG), Diamondback Energy (FANG), and Illumina (ILMN). See the full earnings calendar. Earnings Spotlight, Tuesday, November 5 - Ferrari (RACE), Apollo Global Management (APO), Emerson Electric (EMR), Marathon Petroleum (MPC), Cummins (CMI), Microchip Technology (MCHP), Yum! Brands (YUM), DuPont de Nemours (DD), Restaurant Brands International (QSR), and Archer-Daniels-Midland (ADM). See the full earnings calendar. Earnings Spotlight, Wednesday, November 6 - Novo Nordisk (NVO), Toyota Motor (TM), Qualcomm (QCOM), Arm Holdings (ARM), Gilead Sciences (GILD), MercadoLibre (MELI), CVS Health (CVS), McKesson (MCK), Williams Companies (WMB), Sempra (SRE), Johnson Controls International (JCI), Corteva (CTVA), and Take-Two Interactive Software (TTWO). See the full earnings calendar. Earnings Spotlight, Thursday, November 7 - Arista Networks (ANET), Duke Energy (DUK), Airbnb (ABNB), Petroleo Brasileiro (PBR), Motorola Solutions (MSI), Air Products Chemicals (APD), Becton, Dickinson (BDX), Fortinet (FTNT), and Block (SQ). See the full earnings calendar. Earnings Spotlight, Friday, November 8 - TELUS (TU), NRG Energy (NRG), Baxter International (BAX), Paramount Global (PARA)(PARAA), CNH Industrial (CNH), Fluor (FLR), and Embraer (ERJ). See the full earnings calendar.

I'm over the moon with these results - couldn't be any prouder of our team and this incredible achievement, especially given the current economic landscape! A huge shoutout to our teams, clients, and partners for your hard work, loyalty, and unwavering support. Here’s to even more success as we blast off into FY25! 🚀 #bestteamever #marketresearch #consumerresearch

📈 Magna: Q1 Earnings Snapshot 📊 Summary: Magna, the leading healthcare provider, has reported an impressive financial performance for the first quarter of this year. The company's earnings exceeded expectations, marking a significant milestone for both investors and the healthcare industry as a whole. This news points to a promising future, highlighting the potential growth and profitability of investing in HSA accounts. Magna's strong Q1 earnings provide a clear indication that the healthcare sector continues to flourish, presenting investors with a unique opportunity to secure their financial future while contributing to their well-being and that of their loved ones. Investing in HSA accounts has proven itself as a wise strategy, enabling individuals to grow their wealth while prioritizing their health and family's wellbeing. 💰💼 #HSA #Investing #Healthcare #Health #Family #Wellness 💪💸 Take Action Now to Avoid FOMO! ⏳ Don't miss out on the incredible potential of investing in HSA accounts! Act now and seize the opportunity to maximize your financial growth while securing a healthier future for you and your family. Join the ranks of successful investors who understand the power and significance of aligning their financial goals with their well-being objectives. With Magna's outstanding performance as evidence, it's time to invest in your health and wealth simultaneously. Empower yourself by optimizing your HSA account and embarking on a path towards financial prosperity and a stronger, healthier lifestyle. 🔥📈 Take action today! Invest, grow, and thrive! 🌟💪

📢It's almost time. DHL Group will publish its Q3 2024 results! 📊It’s been a busy quarter for the Group with the launch of DHL’s new Strategy 2030 and lots of roadshow events for the IR team. Now all eyes are on the upcoming Q3 earnings release. We’ll have all the usual financial release content for you here and on our Reporting Hub https://lnkd.in/e7bQ3Q2m And remember to tune in for our investor call 📞as Group CFO Melanie Kreis and CEO Tobias Meyer explain the Group’s latest figures and performance at 10 AM (CET) on November 5. 🗓️Be sure to pencil in the release date. #DHLGroup #DHLInsights #FinancialResults #FinancialUpdate #Q3Results #EarningsCall

**Headings & Subheadings** 1. Congressman Susie Lee Discloses Purchase of RHEINMETALL Stock 2. Stock Performance: RHEINMETALL Declines After Congressional Trade 3. Congress Members Engage in RNMBY Stock Trade Activity **Summary (200 words)** In a recent disclosure, U.S. Representative Susie Lee revealed her purchase of RHEINMETALL stock worth between $1,001 and $15,000 on May 10. However, since the trade was executed, the stock has experienced a decline of approximately 1.74%. This disclosure sheds light on the trading activities of members of Congress, particularly their involvement in RNMBY stock. Members of Congress have engaged in one trade involving RNMBY stock, according to available information. It is a significant revelation that allows investors to gain insight into the investment decisions made by lawmakers. Considering the impact of political decisions on the healthcare sector, observing such trades can provide valuable information for investors seeking exposure to the healthcare industry. With the aim of empowering individuals to make informed investment decisions, it is essential to stay updated on the actions of influential figures within the government. Although stock performance can be influenced by various factors, understanding the trades made by politicians can help investors form a comprehensive view of the market. Avoid the Fear of Missing Out and take charge of your investments. Stay connected to the latest healthcare and investment trends. #HSA #investing #healthcare #health #family #wellness 📈💰🏥

Only put off until tomorrow what you are willing to die having left undone. Cadre (CDRE) Q3 Earnings Report Preview: What To Look For Summary: As we approach the release of Cadre's (CDRE) Q3 earnings report, investors are eagerly anticipating the company's financial performance and future prospects. With the aim of maximizing returns on their investments, it is essential for investors to stay informed about the key factors that may impact Cadre's earnings. This preview provides valuable insights into what to expect from the upcoming report. ⭐️ Inspirational Tone: Don't miss out on potential growth! Act now to secure your financial future and make the most of your Health Savings Account. Headings/Subheadings: 1. 📈 Financial Performance Analysis: - Revenue Growth: Discover how Cadre has been performing in terms of revenue and whether it has met market expectations. - Cost Control Measures: Explore the company's efforts to manage expenses and improve profitability. - Profitability Metrics: Evaluate Cadre's net income, gross margins, and other key profitability indicators. 2. 💼 Business Strategy and Expansion Plans: - Market Opportunities: Gain insights into the company's strategy for capitalizing on emerging trends and opportunities in the real estate industry. - New Partnerships: Learn about Cadre's collaborations and partnerships that could drive future growth. - Expansion Initiatives: Stay updated on the company's plans for geographic expansion and diversification. 3. 🌐 Technological Advancements: - Digital Transformation: Understand how Cadre is leveraging technology to enhance its platform and improve user experience. - Automation and Efficiency: Explore the company's efforts to streamline operations and cut costs through automation and digital solutions. - Data Analytics: Assess Cadre's utilization of data analytics to enhance decision-making and identify investment opportunities. 4. 🌟 Outlook and Guidance: - Future Growth Projections: Gain insights into Cadre's outlook for the coming quarters and its growth expectations. - Guidance and Forecasts: Assess the company's guidance on revenue, profitability, and any potential risks or challenges it may highlight. Don't miss out on the latest updates from Cadre's Q3 earnings report. Stay informed and take action to make the most of your investments in healthcare and secure your financial future. Act now to avoid the Fear of Missing Out! #hsa #investing #healthcare #health #family #wellness 📈💼🌐🌟

Only put off until tomorrow what you are willing to die having left undone 🔮 Axon Earnings: What To Look For From AXON 🔮 📈 As veteran Investment Advisor with extensive experience in investing with HSA accounts, I am excited to bring you the latest insights on Axon's earnings. This leading healthcare company has been making waves in the industry, and it's crucial for investors to stay ahead of the game. 💡 In this report, we will dive deep into what you should look for in Axon's earnings, providing you with valuable information to make informed investment decisions. With the potential for significant growth in the healthcare sector, it's essential to seize the opportunities presented by companies like Axon. ⚡️ Don't miss out on the chance to maximize your HSA investments and grow your wealth. Take action now to avoid the Fear of Missing Out (FOMO) on potential lucrative returns. ✅ Stay tuned for our comprehensive analysis of Axon's earnings, including key financial metrics, revenue growth projections, market trends, and more. It's time to harness the power of your HSA and invest in the future of healthcare. 📣 Join the conversation today and share your thoughts on #hsa #investing #healthcare #health #family #wellness. Let's empower ourselves and make wise investment choices that not only benefit our financial well-being but also contribute to the betterment of our health and the ones we care about. Don't wait any longer – let's unlock the potential of your Health Savings Account together! 💪💰

$UHS - Next financial report will be announced on 23rd of April 2024.: About 99.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.9. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Universal Health Services has Price/Earnings To Growth (PEG) ratio of 1.87. The entity recorded earning per share (EPS) of 10.15. The firm last dividend was issued on the 29th of February 2024. Universal Health had 2:1 split on the 16th of December 2009. https://lnkd.in/gwRseJ_8 #stocks #stocktwits #thematic_portfolio